Covaxin receives GMP certificate from Hungary, says Bharat Biotech | Latest News India - Hindustan Times
close_game
close_game

Covaxin receives GMP certificate from Hungary, says Bharat Biotech

Written by Susmita Pakrasi | Edited by Amit Chaturvedi, Hindustan Times, New Delhi
Aug 05, 2021 10:05 AM IST

Covaxin is among the four vaccines approved by India's drug regulator and is being used in the nationwide inoculation drive.

Indigenous coronavirus disease (Covid-19) vaccine Covaxin has received Good Manufacturing Practices (GMP) compliance certificate from Hungary, Bharat Biotech said on Thursday in a tweet.

The approval was received from the National Institute of Pharmacy and Nutrition, Hungary certifying the GMP for the manufacture of Covaxin.(HT PRINT)
The approval was received from the National Institute of Pharmacy and Nutrition, Hungary certifying the GMP for the manufacture of Covaxin.(HT PRINT)

"Another milestone in our account as COVAXIN receives GMP certificate from Hungary. This marks the 1st EUDRAGDMP compliance certificate received by Bharat Biotech from European regulatories," the tweet said.

Hindustan Times - your fastest source for breaking news! Read now.

The approval was received from the National Institute of Pharmacy and Nutrition, Hungary certifying the GMP for the manufacture of Covaxin.

Bharat Biotech said that the certificate of GMP is now listed on the EudraGMDP database which is the collection of records of the European Community of manufacturing authorisations and certificates of good manufacturing practice.

The company further said that it intends to submit documentation for emergency use authorisation to several additional countries worldwide.

"With this approval Bharat Biotech has achieved another significant milestone in innovating and manufacturing vaccines at Global quality standards and moving forward in the ongoing fight against the COVID-19 pandemic," the company said in a note on Twitter.

The recognition compliments the firm's commitment of driving world class innovation and being a frontrunner in the research and development of vaccines, it added.

"With this approval, Bharat Biotech has achieved another significant milestone in innovating and manufacturing vaccines at global quality standards and moving forward in the ongoing fight against the Covid-19 pandemic," Bharat Biotech said.

Covaxin is among the four vaccines approved by India's drug regulator and is being used in the nationwide inoculation drive. The other three are Covishield by AstraZeneca, Sputnik V by Russia's Gamaleya Institute and a Moderna's vaccine.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Mukhtar Ansari Death News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On